Alps Advisors Inc Innate Pharma Sa Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$2.0 - $3.55 $167,932 - $298,079
-83,966 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.7 - $4.8 $26,330 - $46,809
-9,752 Reduced 10.41%
83,966 $282,000
Q4 2021

Feb 09, 2022
BUY
$4.34 - $6.06 $406,736 - $567,931
93,718 New
93,718 $429,000

Others Institutions Holding IPHA

# of Institutions
9
Shares Held
238K
Call Options Held
0
Put Options Held
0
View Full List

About Innate Pharma SA

IPHA Quotes by TradingView
  • Ticker IPHA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,893,000
  • Market Cap $141M
  • Description
  • Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...
More about IPHA
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email